US Stock MarketDetailed Quotes

BOLD Boundless Bio

Watchlist
  • 2.520
  • -0.140-5.26%
Trading Nov 27 14:13 ET
56.20MMarket Cap-918P/E (TTM)

Boundless Bio Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-8.84%-13.27M
-49.09%-16.24M
-30.49%-15.78M
-18.33%-46.86M
-14.76%-11.69M
-12.86%-12.19M
-10.89M
-12.09M
-70.32%-39.6M
-10.18M
Net income from continuing operations
-25.32%-16.51M
-36.93%-16.98M
-31.67%-15.43M
-7.70%-49.43M
-3.10%-12.14M
-0.37%-13.17M
---12.4M
---11.72M
-82.07%-45.9M
---11.78M
Depreciation and amortization
11.49%262K
11.34%265K
10.97%263K
1.59%957K
3.35%247K
-4.47%235K
--238K
--237K
38.12%942K
--239K
Other non cash items
7.14%645K
17.29%631K
10.75%618K
39.96%2.39M
31.61%687K
-16.62%602K
--538K
--558K
302.84%1.7M
--522K
Change In working capital
197.43%1.62M
-217.17%-587K
4.87%-1.58M
-192.26%-799K
-171.15%-180K
-20.47%544K
--501K
---1.66M
203.46%866K
--253K
-Change in prepaid assets
58.96%550K
-833.33%-1.15M
-211.56%-701K
-60.83%85K
-64.05%87K
38.96%346K
---123K
---225K
113.55%217K
--242K
-Change in payables and accrued expense
108.65%1.78M
7.22%1.25M
76.77%-210K
-12.98%1.66M
-1.08%549K
62.55%855K
--1.16M
---904K
56.13%1.91M
--555K
-Change in other current liabilities
-8.98%-716K
-27.27%-686K
-25.61%-672K
-101.82%-2.55M
-50.00%-816K
-621.98%-657K
---539K
---535K
-174.95%-1.26M
---544K
Cash from discontinued investing activities
Operating cash flow
-8.84%-13.27M
-49.09%-16.24M
-30.49%-15.78M
-18.33%-46.86M
-14.76%-11.69M
-12.86%-12.19M
---10.89M
---12.09M
-70.32%-39.6M
---10.18M
Investing cash flow
Cash flow from continuing investing activities
386.77%22.13M
0.48%-68.19M
-18.18%18.14M
-337.17%-38.26M
89.05%15.81M
-190.41%-7.72M
-68.52M
22.17M
127.21%16.13M
8.36M
Net PPE purchase and sale
-219.87%-483K
-1,075.00%-1.5M
3.49%-83K
40.62%-633K
-587.18%-268K
-32.46%-151K
---128K
---86K
47.59%-1.07M
---39K
Net investment purchase and sale
398.88%22.61M
2.49%-66.69M
-18.12%18.22M
-318.79%-37.63M
91.36%16.08M
-187.47%-7.57M
---68.39M
--22.25M
130.04%17.2M
--8.4M
Cash from discontinued investing activities
Investing cash flow
386.77%22.13M
0.48%-68.19M
-18.18%18.14M
-337.17%-38.26M
89.05%15.81M
-190.41%-7.72M
---68.52M
--22.17M
127.21%16.13M
--8.36M
Financing cash flow
Cash flow from continuing financing activities
97.09%-13K
-9.08%90.65M
-3,080.65%-924K
77,596.03%97.9M
-4,054.29%-1.38M
-1,115.91%-447K
99.7M
31K
-99.88%126K
35K
Net common stock issuance
--0
----
----
----
----
--0
----
----
----
----
Net preferred stock issuance
--0
----
----
--99.67M
---329K
--0
----
----
--0
--0
Proceeds from stock option exercised by employees
--0
--0
90.32%59K
44.44%182K
11.43%39K
95.45%86K
--26K
--31K
-39.42%126K
--35K
Net other financing activities
97.56%-13K
---2.35M
---983K
---1.96M
---1.09M
---533K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
97.09%-13K
-9.08%90.65M
-3,080.65%-924K
77,596.03%97.9M
-4,054.29%-1.38M
-1,115.91%-447K
--99.7M
--31K
-99.88%126K
--35K
Net cash flow
Beginning cash position
-23.77%31.92M
19.04%25.7M
111.30%24.27M
-67.02%11.48M
62.22%21.52M
170.38%41.88M
--21.59M
--11.48M
194.38%34.82M
--13.27M
Current changes in cash
143.49%8.85M
-69.34%6.22M
-85.78%1.44M
154.77%12.78M
253.70%2.74M
-816.80%-20.35M
--20.29M
--10.11M
-201.50%-23.34M
---1.78M
End cash Position
89.44%40.77M
-23.77%31.92M
19.04%25.7M
111.30%24.27M
111.30%24.27M
62.22%21.52M
--41.88M
--21.59M
-67.02%11.48M
--11.48M
Free cash flow
-11.42%-13.75M
-61.01%-17.74M
-30.25%-15.86M
-16.79%-47.49M
-16.94%-11.95M
-13.07%-12.34M
---11.02M
---12.18M
-60.83%-40.66M
---10.22M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -8.84%-13.27M-49.09%-16.24M-30.49%-15.78M-18.33%-46.86M-14.76%-11.69M-12.86%-12.19M-10.89M-12.09M-70.32%-39.6M-10.18M
Net income from continuing operations -25.32%-16.51M-36.93%-16.98M-31.67%-15.43M-7.70%-49.43M-3.10%-12.14M-0.37%-13.17M---12.4M---11.72M-82.07%-45.9M---11.78M
Depreciation and amortization 11.49%262K11.34%265K10.97%263K1.59%957K3.35%247K-4.47%235K--238K--237K38.12%942K--239K
Other non cash items 7.14%645K17.29%631K10.75%618K39.96%2.39M31.61%687K-16.62%602K--538K--558K302.84%1.7M--522K
Change In working capital 197.43%1.62M-217.17%-587K4.87%-1.58M-192.26%-799K-171.15%-180K-20.47%544K--501K---1.66M203.46%866K--253K
-Change in prepaid assets 58.96%550K-833.33%-1.15M-211.56%-701K-60.83%85K-64.05%87K38.96%346K---123K---225K113.55%217K--242K
-Change in payables and accrued expense 108.65%1.78M7.22%1.25M76.77%-210K-12.98%1.66M-1.08%549K62.55%855K--1.16M---904K56.13%1.91M--555K
-Change in other current liabilities -8.98%-716K-27.27%-686K-25.61%-672K-101.82%-2.55M-50.00%-816K-621.98%-657K---539K---535K-174.95%-1.26M---544K
Cash from discontinued investing activities
Operating cash flow -8.84%-13.27M-49.09%-16.24M-30.49%-15.78M-18.33%-46.86M-14.76%-11.69M-12.86%-12.19M---10.89M---12.09M-70.32%-39.6M---10.18M
Investing cash flow
Cash flow from continuing investing activities 386.77%22.13M0.48%-68.19M-18.18%18.14M-337.17%-38.26M89.05%15.81M-190.41%-7.72M-68.52M22.17M127.21%16.13M8.36M
Net PPE purchase and sale -219.87%-483K-1,075.00%-1.5M3.49%-83K40.62%-633K-587.18%-268K-32.46%-151K---128K---86K47.59%-1.07M---39K
Net investment purchase and sale 398.88%22.61M2.49%-66.69M-18.12%18.22M-318.79%-37.63M91.36%16.08M-187.47%-7.57M---68.39M--22.25M130.04%17.2M--8.4M
Cash from discontinued investing activities
Investing cash flow 386.77%22.13M0.48%-68.19M-18.18%18.14M-337.17%-38.26M89.05%15.81M-190.41%-7.72M---68.52M--22.17M127.21%16.13M--8.36M
Financing cash flow
Cash flow from continuing financing activities 97.09%-13K-9.08%90.65M-3,080.65%-924K77,596.03%97.9M-4,054.29%-1.38M-1,115.91%-447K99.7M31K-99.88%126K35K
Net common stock issuance --0------------------0----------------
Net preferred stock issuance --0----------99.67M---329K--0----------0--0
Proceeds from stock option exercised by employees --0--090.32%59K44.44%182K11.43%39K95.45%86K--26K--31K-39.42%126K--35K
Net other financing activities 97.56%-13K---2.35M---983K---1.96M---1.09M---533K----------------
Cash from discontinued financing activities
Financing cash flow 97.09%-13K-9.08%90.65M-3,080.65%-924K77,596.03%97.9M-4,054.29%-1.38M-1,115.91%-447K--99.7M--31K-99.88%126K--35K
Net cash flow
Beginning cash position -23.77%31.92M19.04%25.7M111.30%24.27M-67.02%11.48M62.22%21.52M170.38%41.88M--21.59M--11.48M194.38%34.82M--13.27M
Current changes in cash 143.49%8.85M-69.34%6.22M-85.78%1.44M154.77%12.78M253.70%2.74M-816.80%-20.35M--20.29M--10.11M-201.50%-23.34M---1.78M
End cash Position 89.44%40.77M-23.77%31.92M19.04%25.7M111.30%24.27M111.30%24.27M62.22%21.52M--41.88M--21.59M-67.02%11.48M--11.48M
Free cash flow -11.42%-13.75M-61.01%-17.74M-30.25%-15.86M-16.79%-47.49M-16.94%-11.95M-13.07%-12.34M---11.02M---12.18M-60.83%-40.66M---10.22M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data